Atlas Trials

Residual Vein Thrombosis and the Optimal Duration of Low Molecular Weight Heparin in Cancer Patients With Deep Vein Thrombosis

Clinical trial NCT00450645 · UNKNOWN

Trial details

NCT number
NCT00450645
Sponsor
Azienda Ospedaliera Universitaria Policlinico
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Deep Vein ThrombosisCancer
Start date
2005-03-01
Primary completion
2009-03-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.